Kailey Mullins previously interned at Gilead Sciences and CareDx, gaining experience in quality assurance, lab operations, and built a database to manage legacy documentation. She also worked at Outlier AI, training models to improve biological accuracy. As part of her master’s, she is conducting CRISPR research on the p53 pathway in cancer. Kailey holds a B.S. in Biology with a minor in Neuroscience from the University of San Francisco and is completing her Professional Science Master’s in Biotechnology.